Can Chinese Osmanthus Extract Be Used in US Dietary Supplements? A Complete NDI Notification Guide for Import Buyers

⚠️ Osmanthus extract cannot be legally sold as a dietary supplement ingredient in the United States unless the manufacturer or importing brand has submitted and received no objection from the FDA through the New Dietary Ingredient (NDI) notification process under 21 U.S.C. § 350b(a)(2). As a dietary supplement brand buyer evaluating Chinese osmanthus (Osmanthus fragrans) extract for your product pipeline, you need to understand exactly what the NDI process requires, what documents your supplier must provide, and how to verify compliance before placing an order. This guide walks through every step from regulatory fundamentals to actionable procurement decisions. ---

What Is the NDI Notification and Why Is It Required for Osmanthus Extract?

Under the Dietary Supplement Health and Education Act (DSHEA) of 1994, any dietary ingredient that was not marketed in the United States in a dietary supplement before October 15, 1994 is considered a "new dietary ingredient" and requires an NDI notification to the FDA at least 75 days before introduction into interstate commerce. Chinese osmanthus extract — typically standardized for acteoside, verbascoside, or total flavonoids — does not have an established history of use in US dietary supplements prior to the 1994 cutoff. This means:

• It does not qualify for the "grandfathered" pre-DSHEA exemption
• It cannot rely solely on Chinese food-use history to bypass NDI
• An NDI notification must be filed by the manufacturer or brand owner before the first sale in the US market

> Note: The HHS/FDA March 2025 GRAS reform proposal has introduced stricter standards for botanical safety submissions, raising the evidentiary bar for non-NDI pathways. This makes early NDI planning even more critical for Chinese-origin botanical ingredients. ---

How Does the FDA Classify Chinese Osmanthus Extract: NDI, GRAS, or Conventional Food?

Many import buyers ask whether osmanthus extract can take an alternative pathway. The table below clarifies the three possible classifications and their applicability. Key takeaway for buyers: The NDI notification is the most realistic compliance pathway for osmanthus extract as a supplement ingredient. Never accept a supplier's claim that "it's GRAS" without a verifiable FDA GRAS Notice number (GRN) — and even then, confirm the GRN covers supplement use, not just food use. ---

What Documents Must Your Chinese Supplier Provide for NDI Notification?

A successful NDI submission depends on a complete technical dossier. As the buyer, you must verify that your supplier can deliver all of the following: ---

How to Evaluate a Chinese Osmanthus Extract Supplier's NDI Readiness: A 4-Step Checklist

Step 1: Verify FDA Establishment Registration

• Ask for the supplier's FDA FEI number (Foreign Establishment Identifier)
• Confirm the registration is current (renewed every even year by Dec 31)
• Cross-check against the FDA's publicly available registered facilities list

Step 2: Confirm NDI Status

• Does the supplier have an existing NDI notification number for osmanthus extract?
• If yes: request the FDA acknowledgment letter and verify the notification covers your proposed use level and dosage form
• If no: ask whether they have submitted a notification, at what stage, and what objection(s) the FDA raised (if any)

Step 3: Audit the Quality Management System

• Request a current cGMP certificate from a recognized third-party auditor (e.g., NSF, SGS, UL)
• Verify the scope explicitly includes dietary supplement manufacturing (not just food or cosmetics)
• Schedule a remote or on-site quality audit using the NPA (Natural Products Association) or NSF GMP checklist

Step 4: Request Lot-Specific Compliance Evidence

• Ask for at least 3 consecutive COAs to assess batch consistency
• Request stability data (real-time, 12-month minimum) for the target extract
• Confirm third-party lab testing for USP <232>/<233> heavy metals and USP <61>/<62> microbial limits

> Buyer's tip: Request a sample lot and arrange independent third-party testing (e.g., Eurofins, Intertek) to verify the COA claims before committing to volume. ---

FAQ

1. If my Chinese supplier has a GRAS self-determination for osmanthus extract, can I use it in supplements without NDI?

No. A GRAS self-determination addresses safety for food use, not dietary supplement use. The FDA requires separate NDI notification for supplement applications unless the ingredient was marketed in supplements prior to October 15, 1994. Always ask for a GRAS Notice number (GRN) issued by FDA, not just a self-affirmation letter.

2. How long does the NDI notification process typically take?

Minimum 75 days (the FDA review period after submission), but preparation of the technical dossier — including safety studies, literature reviews, and identity documentation — typically takes 4 to 12 months depending on data availability. Budget a total lead time of 9 to 15 months from dossier start to FDA clearance.

3. What happens if I import osmanthus extract for R&D without an NDI notification?

Importing for legitimate R&D (non-commercial quantities, not for sale) has limited exceptions under 21 CFR 110.20, but the burden of proof is on the importer. Customs may detain the shipment if it resembles a commercial lot. For any quantity destined for finished product formulation, NDI notification is required.

4. What are the penalties for selling an osmanthus supplement without NDI notification?

The FDA can issue a Warning Letter, mandate a voluntary recall, seek product seizure through the Department of Justice, and in egregious cases pursue criminal penalties (21 U.S.C. § 333). The financial impact includes destroyed inventory, legal costs, and reputational damage that can bar future FDA engagement.

5. Does my Chinese supplier need separate NDI notification if my US brand already has one?

No — the notification is per manufacturer. If your US brand holds the NDI notification, your Chinese supplier simply needs to manufacture to the spec listed in that notification. However, if the supplier changes the extraction process, solvent, or standardization markers, a new or amended NDI notification may be required.

6. Can osmanthus extract from China meet FDA's heavy metal limits for supplements?

Yes — provided the supplier operates a controlled extraction process. FDA expects compliance with USP limits: lead ≤0.5 ppm, arsenic ≤1.0 ppm, cadmium ≤0.5 ppm, and mercury ≤0.5 ppm. Chinese suppliers with integrated planting bases and ICP-MS testing equipment can consistently meet these limits.

7. What is the typical cost of completing an NDI notification?

Industry estimates range from $25,000 to $100,000+ depending on the complexity of the ingredient, availability of existing safety data, and whether new toxicology studies must be commissioned. Budget $50,000–$75,000 as a realistic range for a botanical extract like osmanthus.

8. How can I verify whether a supplier's NDI notification number is genuine?

Request the FDA acknowledgment letter (with letterhead and date), then ask the supplier to check their NDI submission status via the FDA's electronic submission portal. You can also submit a FOIA request to FDA for notification records, though this takes several weeks. ---

Conclusion: Does Your Procurement Strategy Cover NDI Compliance?

Chinese osmanthus extract offers strong antioxidant and anti-inflammatory properties that appeal to the US supplement market — but the regulatory gate is unmistakable: no NDI notification means no compliant market entry. With the 2025 GRAS reform tightening botanical safety expectations, the window for shortcuts is firmly closed. The risk is not just regulatory; it is commercial. Brands that back a supplier without NDI readiness face delayed product launches, seized inventory, and damaged retailer relationships. For buyers, NDI compliance is not a legal department problem — it is a supplier qualification criterion baked into every RFQ and purchase order.

Next Steps for Buyers (Do These This Week)

1. Audit your current pipeline — For any osmanthus extract product in development, confirm whether an NDI notification has been filed or obtained.
2. Request the NDI dossier checklist — Send your shortlisted suppliers the document requirements in Section III above. Give them 2 weeks to confirm completeness.
3. Flag non-NDI suppliers — Remove from consideration any supplier who cannot produce an FDA establishment registration or a submitted NDI notification number.
4. Budget for compliance costs — Factor $50,000–$75,000 into the product launch budget for NDI notification fees and consultant/regulatory support.
5. Engage a regulatory consultant — If your brand lacks in-house FDA regulatory experience, retain a food-and-supplement regulatory specialist before selecting your final supplier.

> Bottom line for buyers: A supplier's NDI readiness directly predicts your product's speed to market and regulatory risk exposure. Verify it before you commit.

This article was published on June 27, 2026, and last updated on June 27, 2026. The article will be continuously updated.